Celebrating 20 Years of IP Excellence

Patent Claims x

Pfizer files for Patent on Known Substance

  This is in furtherance of Gaurav's post with respect to refusal of Pfizer Patent by the Indian Patent Office. I do not wish to repeat the facts or reiterate the order. However, I would like to bring forth one  aspect of the order that seems to  contradict the  Novartis decision of the Supreme Court. In the Novartis case, the Supreme Court clearly laid down that  assessment of subject matter and novelty/inventive step cannot be merged, and they are two segregate…

Read more